CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. We have a reputation for rigorous and innovative analysis, careful attention to detail, and the ability to work effectively as part of a wider team of advisers.Ĭharles River Associates® is a leading global consulting firm specializing in economic, financial, and management consulting services. We provide the analytical expertise and industry experience needed to address our clients’ toughest issues. The CRA Life Sciences Practice works with leading biotech, medical device, and pharmaceutical companies law firms regulatory agencies and national and international industry associations. Ghosh has a MS in Chemical Engineering from Columbia University and a BS in Chemical Biological Engineering from the Massachusetts Institute of Technology. He started his career as a scientist at a large, multinational pharmaceutical company where he focused on process optimization and commercialization of novel biologics. Previously, he drove commercial, market access, and corporate strategy engagements at a management consulting firm specializing in the biopharmaceutical industry. He led a team of more than 20 consultants across major accounts and alliance partnerships with a focus on gene therapy, rare disease, and oncology. Prior to joining CRA, Ghosh led several practice areas, key partnerships, and biotech investments as a senior vice president for a life sciences-focused boutique consulting firm. Bell, Group Vice President and Life Sciences Practice Leader. “Ayushman has the perspective of both an industry veteran and an experienced consultant, which is an invaluable asset in working with life sciences companies, particularly in helping them to develop and implement commercialization and product launch strategies,” said Dr. “I am pleased to welcome him to CRA, where he is joining a team that has long been recognized for its ability to provide clarity and solutions for the industry’s most complex issues.” “Ayushman has deep expertise in advising life sciences clients on commercial, clinical, medical, and manufacturing strategy in the gene therapy, rare disease, and oncology spaces,” said Paul Maleh, CRA’s Chairman and Chief Executive Officer. An archived version of the webcast, press release, and financial information will be available on CRA’s website for one year.BOSTON-(BUSINESS WIRE)- Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced that Ayushman Ghosh has joined the company’s Life Sciences Practice as a vice president. Prior to the call, CRA will post the press release announcing its first-quarter 2023 financial results and supplemental financial information, including prepared CFO remarks, on the “ Investor Relations” section of its website. To listen to a live webcast of the call, please visit the “ Investor Relations” section of CRA’s website at. The conference call will be hosted by President and Chief Executive Officer Paul Maleh, Chief Financial Officer Daniel Mahoney and Chief Corporate Development Officer Chad Holmes. Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that CRA will webcast its first-quarter 2023 financial results conference call on Thursday, at 10:00 a.m.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |